Fig. 2
Therapeutic response of PDX models and corresponding patients. Five PDX models of ESCC were evaluated for therapeutic responses compared to corresponding patients. Better response was seen in PDX models with tumor tissue from patients with partial responses (a, b) compared to those with stable disease (c, d). Case EC1 (patient with progressive disease) had a minimum response (e). TGI and response for corresponding patients are given (f)